drugset / Trial / NCT01225068
Effect of Milnacipran in Chronic Neuropathic Low Back Pain
Phase 2
Completed
40 enrolled
Northwestern University
Best Practice · collabForest Laboratories · collabShirley Ryan AbilityLab · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Low back pain is a public health problem affecting between 70-85% of adults at some time in their life. This study is being done to study the safety and effectiveness of the drug Milnacipran in treating chronic low back pain.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-01
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milnacipran | Other / unclassified | 50 mg | — |
Indications
No indication recorded.